Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

Lancet

Volumn 353, Issue 9150, 1999, Pages 359-363

  Roth, Willi Kurt ^a   Weber, Marijke ^a   Seifried, Erhard ^a  

^a Inst Transfus Med I   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; ALANINE AMINOTRANSFERASE; HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; BLOOD BANK; BLOOD DONOR; CENTRIFUGATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GEL ELECTROPHORESIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK; SCREENING; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0033616491     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)06318-1     Document Type: Article

References (18)

1. for the Retrovirus Epidemiology Donor Study, Schreiber G.B., Busch M.P., Kleinman S.H., Koreliz J.J. The risk of transfusion-transmitted viral infections. N Engl J Med. 334:1996;1685-1690.
2. Vrielink H., Reesink H.W., van den Burg P.J.M., Zaaijer H.L., Cuypers H.T.M., Lelie P.N., van der Pool C.L. Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients. Transfusion. 37:1997;845-849.
3. Lackritz E., Satten G.A., Aberle-Grasse J., et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med. 333:1995;1721-1725.
4. Hewlett I.K., Epstein J.S. Food and drug administration conference on the feasibility of genetic technology to close the HIV window in donor screening. Transfusion. 37:1997;346-351.
5. Farci P., Alter H.J., Wong D., et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med. 325:1991;98-104.
6. the study group Berufsverband Deutscher Transfusionsmediziner e V, Glück D., Maurer C., Kubanek B. HIV, HCV and HBV in blood donors. Infusionsther Transfusionsmed. 24:1997;167-170.
7. Diekamp U, Kamutzky K, Windel C-D. Prevalence and incidence of anti-HCV in 2·8 million blood donations in lower Saxony-HCV risk associated with transfusions [German]. In: Sibrowski W, Stangel W, Müller N, eds. Transfusionsmedizin 1996/97. Beitr Infusionsther Transfusionsmed. Basel: Karger, 1997; 34: 5-10.
8. Rüster B., Zeuzem S., Roth W.K. Quantification of hepatitis C virus RNA by competitive reverse transcription and polymerase chain reaction using a modified hepatitis C virus RNA transcript. Anal Biochem. 224:1995;597-600.
9. Yukosuka O, Tagawa M, Omata M. PCR detection of hepatitis B virus. In: Persing DH, Smith DF, Tenover FC, White TJ, eds. Diagnostic Molecular Microbiology. American Society of Microbiology, 1993; 322-6.
10. Whetsell A.J., Drew J.B., Milman G., et al. Comparison of three nonradioisotopic polymerase chain reaction-based methods for detection of human immunodeficiency virus type 1. J Clin Microbiol. 30:1992;845-853.
11. Kwok S., Higushi R. Avoiding false positives with PCR. Nature. 339:1989;237-238.
12. Paul-Ehrlich-Institut, Bundesamt für Sera und Impfstoffe, Germany. Results of the phased plan to reduce the infection risk in hepatitis B, C, and HIV in recipients of packed red cell transfusions [German]. Bundesanzeiger 1998; 53: 3835-36.
13. Zayc-Schmidt E-M, Schottstedt V, Tuma W, Bünger G, Lefevre H. Identification of a single viremic donation with PCR-minipool-testing in a large blood bank (abstr). Infusionsther Transfusionsmed 1997; 24: 195, A-121.
14. Livak K.J., Flood S.J., Marmaro J., Giusti W., Deetz K. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detection PCR product and nucleic acid hybridization. PCR Methods Applic. 4:1995;357-362.
15. Herrera G.A., Lackritz E.M., Janssen R.S., et al. Serologic test for syphilis as a surrogate marker for human immunodeficiency virus infection among United States blood donors. Transfusion. 37:1997;836-840.
16. the Retrovirus Epidemiology Donor Study, Busch M.P., Korelitz J.J., Kleinman S.H., Lee S.R., AuBuchon J.P., Schreiber G.B. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C infection. Transfusion. 35:1995;903-910.
17. Prince A.M., Scheffel J.W., Moore B. A search for hepatitis C virus polymerase chain reaction-positive but seronegative subjects among blood donors with elevated alanine aminotransferase. Transfusion. 37:1997;211-214.
18. Shindo M., Di Bisceglie A.M., Biswas R., et al. Hepatitis C virus replication during acute infection in the chimpanzee. J Infect Dis. 166:1992;424-427.